205 related articles for article (PubMed ID: 34082797)
1. Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization.
Ray U; Roy D; Jin L; Thirusangu P; Staub J; Xiao Y; Kalogera E; Wahner Hendrickson AE; Cullen GD; Goergen K; Oberg AL; Shridhar V
J Exp Clin Cancer Res; 2021 Jun; 40(1):182. PubMed ID: 34082797
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers.
Mondal S; Roy D; Sarkar Bhattacharya S; Jin L; Jung D; Zhang S; Kalogera E; Staub J; Wang Y; Xuyang W; Khurana A; Chien J; Telang S; Chesney J; Tapolsky G; Petras D; Shridhar V
Int J Cancer; 2019 Jan; 144(1):178-189. PubMed ID: 30226266
[TBL] [Abstract][Full Text] [Related]
3. Loss of HSulf-1: The Missing Link between Autophagy and Lipid Droplets in Ovarian Cancer.
Roy D; Mondal S; Khurana A; Jung DB; Hoffmann R; He X; Kalogera E; Dierks T; Hammond E; Dredge K; Shridhar V
Sci Rep; 2017 Feb; 7():41977. PubMed ID: 28169314
[TBL] [Abstract][Full Text] [Related]
4. Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis.
Sato H; Kato R; Isogai Y; Saka G; Ohtsuki M; Taketomi Y; Yamamoto K; Tsutsumi K; Yamada J; Masuda S; Ishikawa Y; Ishii T; Kobayashi T; Ikeda K; Taguchi R; Hatakeyama S; Hara S; Kudo I; Itabe H; Murakami M
J Biol Chem; 2008 Nov; 283(48):33483-97. PubMed ID: 18801741
[TBL] [Abstract][Full Text] [Related]
5. JS-K, a nitric oxide donor, induces autophagy as a complementary mechanism inhibiting ovarian cancer.
Liu B; Huang X; Li Y; Liao W; Li M; Liu Y; He R; Feng D; Zhu R; Kurihara H
BMC Cancer; 2019 Jul; 19(1):645. PubMed ID: 31262254
[TBL] [Abstract][Full Text] [Related]
6. Group III secreted phospholipase A2 regulates epididymal sperm maturation and fertility in mice.
Sato H; Taketomi Y; Isogai Y; Miki Y; Yamamoto K; Masuda S; Hosono T; Arata S; Ishikawa Y; Ishii T; Kobayashi T; Nakanishi H; Ikeda K; Taguchi R; Hara S; Kudo I; Murakami M
J Clin Invest; 2010 May; 120(5):1400-14. PubMed ID: 20424323
[TBL] [Abstract][Full Text] [Related]
7. Group III secreted phospholipase A2 transgenic mice spontaneously develop inflammation.
Sato H; Taketomi Y; Isogai Y; Masuda S; Kobayashi T; Yamamoto K; Murakami M
Biochem J; 2009 Jun; 421(1):17-27. PubMed ID: 19371233
[TBL] [Abstract][Full Text] [Related]
8. Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance.
Mukherjee A; Chiang CY; Daifotis HA; Nieman KM; Fahrmann JF; Lastra RR; Romero IL; Fiehn O; Lengyel E
Cancer Res; 2020 Apr; 80(8):1748-1761. PubMed ID: 32054768
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer.
Xiao Y; Jin L; Deng C; Guan Y; Kalogera E; Ray U; Thirusangu P; Staub J; Sarkar Bhattacharya S; Xu H; Fang X; Shridhar V
Oncogene; 2021 Feb; 40(8):1409-1424. PubMed ID: 33420377
[TBL] [Abstract][Full Text] [Related]
10. Primary cilium suppression by SREBP1c involves distortion of vesicular trafficking by PLA2G3.
Gijs HL; Willemarck N; Vanderhoydonc F; Khan NA; Dehairs J; Derua R; Waelkens E; Taketomi Y; Murakami M; Agostinis P; Annaert W; Swinnen JV
Mol Biol Cell; 2015 Jun; 26(12):2321-32. PubMed ID: 25904332
[TBL] [Abstract][Full Text] [Related]
11. Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibition.
Blessing AM; Santiago-O'Farrill JM; Mao W; Pang L; Ning J; Pak D; Bollu LR; Rask P; Iles L; Yang H; Tran S; Elmir E; Bartholomeusz G; Langley R; Lu Z; Bast RC
Cancer; 2020 Aug; 126(15):3579-3592. PubMed ID: 32484926
[TBL] [Abstract][Full Text] [Related]
12. Role of cystathionine beta synthase in lipid metabolism in ovarian cancer.
Chakraborty PK; Xiong X; Mustafi SB; Saha S; Dhanasekaran D; Mandal NA; McMeekin S; Bhattacharya R; Mukherjee P
Oncotarget; 2015 Nov; 6(35):37367-84. PubMed ID: 26452259
[TBL] [Abstract][Full Text] [Related]
13. Emblica officinalis extract induces autophagy and inhibits human ovarian cancer cell proliferation, angiogenesis, growth of mouse xenograft tumors.
De A; De A; Papasian C; Hentges S; Banerjee S; Haque I; Banerjee SK
PLoS One; 2013; 8(8):e72748. PubMed ID: 24133573
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Phospholipase A2 Group 3 Expression by Oxidative Stress Decreases the Insulin-Degrading Enzyme.
Yui D; Nishida Y; Nishina T; Mogushi K; Tajiri M; Ishibashi S; Ajioka I; Ishikawa K; Mizusawa H; Murayama S; Yokota T
PLoS One; 2015; 10(12):e0143518. PubMed ID: 26637123
[TBL] [Abstract][Full Text] [Related]
15. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of in vitro and in vivo ovarian cancer cell growth by pinoresinol occurs by way of inducing autophagy, inhibition of cell invasion, loss of mitochondrial membrane potential and inhibition Ras/MEK/ERK signalling pathway.
Ning Y; Fu YL; Zhang QH; Zhang C; Chen Y
J BUON; 2019; 24(2):709-714. PubMed ID: 31128027
[TBL] [Abstract][Full Text] [Related]
17. Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer.
Ziebarth AJ; Nowsheen S; Steg AD; Shah MM; Katre AA; Dobbin ZC; Han HD; Lopez-Berestein G; Sood AK; Conner M; Yang ES; Landen CN
Clin Cancer Res; 2013 Jan; 19(1):170-82. PubMed ID: 23147994
[TBL] [Abstract][Full Text] [Related]
18. Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis.
Taketomi Y; Ueno N; Kojima T; Sato H; Murase R; Yamamoto K; Tanaka S; Sakanaka M; Nakamura M; Nishito Y; Kawana M; Kambe N; Ikeda K; Taguchi R; Nakamizo S; Kabashima K; Gelb MH; Arita M; Yokomizo T; Nakamura M; Watanabe K; Hirai H; Nakamura M; Okayama Y; Ra C; Aritake K; Urade Y; Morimoto K; Sugimoto Y; Shimizu T; Narumiya S; Hara S; Murakami M
Nat Immunol; 2013 Jun; 14(6):554-63. PubMed ID: 23624557
[TBL] [Abstract][Full Text] [Related]
19. Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target.
Saini U; Naidu S; ElNaggar AC; Bid HK; Wallbillich JJ; Bixel K; Bolyard C; Suarez AA; Kaur B; Kuppusamy P; Hays J; Goodfellow PJ; Cohn DE; Selvendiran K
Oncogene; 2017 Jan; 36(2):168-181. PubMed ID: 27292260
[TBL] [Abstract][Full Text] [Related]
20. Serotonin/HTR1E signaling blocks chronic stress-promoted progression of ovarian cancer.
Qin X; Li J; Wang S; Lv J; Luan F; Liu Y; Chen Y; Chen X; Zhao Y; Zhu J; Piao Y; Zhang W; Shi Y; Xiang R; Qu P; Wang L
Theranostics; 2021; 11(14):6950-6965. PubMed ID: 34093864
[No Abstract] [Full Text] [Related]
[Next] [New Search]
